Jamie Barkin is a Gastroenterology physician affiliated with University of Miami. OpenAlex indexes 6 publications with 207 citations (h-index 6); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1120 NW 14th St
11th Floor Crb, Room 1116
Miami, FL 331362107
Telephone
305-243-8644Registry record last updated 4 Sept 2014.
Clinical trials
- Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
Sponsor: Mt. Sinai Medical Center, Miami
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20231 payment
- BOSTON SCIENTIFIC CORPORATIONProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Proton pump inhibitor100%Omeprazole79%Pantoprazole Sodium21%Part D≥25 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- REVIEW: Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
Digestive Diseases and Sciences
2000 - Pancreatic Supplements Reduce Symptomatic Response of Healthy Subjects to a High Fat Meal
Digestive Diseases and Sciences
1999 - Occult Gastrointestinal Bleeding: General Overview and Approach
Gastrointestinal Endoscopy Clinics of North America
1996 - First-generation video enteroscope: Fourth-generation push-type small bowel enteroscopy utilizing an overtube
Gastrointestinal Endoscopy
1994
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Myerburg, MD
University of Miami
Thomas Hooton, MD
University of Miami
Harry Flynn, MD
University of Miami
Alan Wein, MD
University of Miami
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”